Repositori DSpace/Manakin

Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.

Mostra el registre parcial de l'element

dc.creator González-Huix Lladó, Ferran
dc.creator León, R. de
dc.creator Fernández Bañares, Fernando
dc.creator Esteve i Comas, Maria
dc.creator Cabré i Gelada, Eduard
dc.creator Acero i Fernández, Doroteo
dc.creator Abad, Águeda
dc.creator Figa, M.
dc.creator Guilera Sardà, Magda
dc.creator Planas Vilà, Ramon
dc.creator Gassull, Miquel Àngel
dc.date 2011-07-07T12:31:02Z
dc.date 2011-07-07T12:31:02Z
dc.date 1993
dc.date.accessioned 2024-12-16T10:27:16Z
dc.date.available 2024-12-16T10:27:16Z
dc.identifier 0017-5749
dc.identifier http://hdl.handle.net/2445/18678
dc.identifier 160892
dc.identifier 8314510
dc.identifier.uri http://fima-docencia.ub.edu:8080/xmlui/handle/123456789/22178
dc.description Thirty two patients with active Crohn's disease were included in a controlled randomised trial to determine the efficacy and safety of polymeric enteral nutrition compared with steroids, to achieve and maintain clinical remission. The polymeric diet was administered through a fine bore nasogastric tube by continuous, pump assisted infusion (2800 (SEM 120) kcal/day). The steroid group received 1 mg/kg/day of prednisone. Both treatments were effective in inducing clinical remission: 15 of the 17 patients given steroids and 12 of the 15 patients assigned to the polymeric diet went into clinical remission (defined by a Van Hees index < 120) within four weeks of treatment. The percentage reduction of the Van Hees index was 34.8 (4.9)% for steroids and 32.3 (5)% for enteral nutrition (mean difference 2.5%; 95% CI--11.8% to +16.8%). Mean time elapsed to achieve remission was similar in both groups (2.0 (1) v 2.4 (1.2) weeks). Tolerance of the enteral diet was excellent. Four patients in the steroid group had mild complications attributable to this treatment. Ten patients (66.6%) in the steroid group and five (41.6%) in the enteral nutrition group relapsed within a year of discharge, but no differences were found in the cumulative probability of relapse during the follow up period. These results suggest that polymeric enteral nutrition is as safe and effective as steroids in inducing short term remission in active Crohn's disease.
dc.format 5 p.
dc.format application/pdf
dc.language eng
dc.publisher BMJ Group
dc.relation Reproducció digital del document publicat a: http://dx.doi.org/10.1136/gut.34.6.778
dc.relation Gut, 1993, vol. 34, núm. 6, p. 778-782
dc.relation http://dx.doi.org/10.1136/gut.34.6.778
dc.rights (c) BMJ Publishing Group Ltd and British Society of Gastroenterology, 1993
dc.rights info:eu-repo/semantics/openAccess
dc.source Articles publicats en revistes (Medicina)
dc.subject Alimentació enteral
dc.subject Malaltia de Crohn
dc.subject Assaigs clínics
dc.subject Esteroides
dc.subject Enteral feeding
dc.subject Crohn's disease
dc.subject Clinical trials
dc.subject Steroids
dc.title Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.
dc.type info:eu-repo/semantics/article
dc.type info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

Fitxers Grandària Format Visualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a DSpace


Cerca avançada

Visualitza

El meu compte